On ECHEMI
Home > Drugs > Leiomyosarcoma
Leiomyosarcoma
Leiomyosarcoma is a malignant tumor originating from smooth muscle. It is common in men over 40 years old and presents as a single or several nodules with a diameter of no more than 5 cm. The prognosis of the tumor is closely related to its location and size.
  • Site of disease:

    Blood vessels of lower limbs
  • Infectious :

    Not contagious
  • Frequent population:

    Age 40-60
  • Related symptoms:

    Nodule pain muscle tear muscle contracture cystic mass
Related Drugs
Dacarbazine for injection
Indication: This product is used to treat malignant melanoma
Manufacturer:

Nanjing Pharmaceutical FACTORY Co., Ltd.

Actinomycin D for injection
Indication: 1. It has outstanding efficacy in the treatment of Hodgkin's disease (HD) and neuroblastoma, especially in controlling fever. 2. The cure rate of this drug alone for the initial treatment of non-metastatic choriocarcinoma is 90% to 100%, which is similar to the effect of MTX alone. 3. It is also effective for testicular cancer, and is generally used in combination with other drugs. 4. Combining it with radiotherapy to treat childhood Wilms tumor can improve the survival rate, and it is also effective for Ewing sarcoma and rhabdomyosarcoma.
Manufacturer:

Han Hui Pharmaceuticals Company Limited

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.